An increase in capillary permeabilty is a common pathophysiological state in critical illness such as SIRS, capillary leak syndrome and after trauma. Terbutaline and theophyllamine have been used to reduce the capillary leakage without convincing effects. It has been shown in this laboratory and by others that the endothelial produced substance prostacyclin reduces capillary permeability. Prostacyclin is also an inhibitor of platelet aggregation, a vasodilator and has cytoprotective effects. The aim of this study was to compare the permeability reducing effect of prostacyclin with terbutaline and theophyllamine. The observations were made on an autoperfused, denervated cat gastrocnemius muscle enclosed in a plethysmograph with continuous recording of volume changes, arterial and venous blood pressures and flow. Twelve cats, anaesthetized with ketamine were used. The capillary filtration coefficient (CFC), reflecting the capillary surface area for fluid exchange, was determined by the rate of a steady-state increase in tissue volume per min after an increase in venous pressure of 5 mmHg. A change in CFC reflects a change in capillary permeability but the number of open capillaries is also of importance. CFC determinations were carried out using intravenous infusion of different doses of each drug alone. Further, the three drugs were given separately during simultaneous local intra-arterial infusion of TNFα (0.75 μg 100 g−1 muscle min−1) or histamine (50 μg 100 g−1 muscle min−1), respectively. Prostacyclin in doses of 2, 5, 10, 20, 40 and 60 ng kg−1 min−1 reduced CFC from a control value of 0.012±0.001 (SEM) ml (min mmHg 100 g−1) reaching maximum reduction of 28% at 20 ng kg−1 min−1 (P<0.001), 2 ng kg−1 reduced CFC by 16% and 5 ng kg−1 min−1 by 18% (P<0.01). TNFα and histamine significantly increased CFC by 57 and 72% respectively. Infusion of prostacyclin 2 ng kg−1 min−1 reduced the TNFα induced increase in CFC to 17% below the initial control value with maximal reduction of 23% obtained at 20 ng kg−1 min−1. During histamine infusion, the same reduction of 23% was obtained but at the dose of 10 ng kg−1 min−1 of prostacyclin. Terbutaline in doses of 3.5, 7 and 14 μg kg−1 bw h−1 and theophyllamine in doses of 12.5, 25 and 50 mg kg−1 h did not reduce CFC from the control value. Both terbutaline and theophyllamine had some, though non-significant, reducing effect on the increased CFC values during the TNFα and histamine infusions. However, terbutaline and theophyllamine caused vasodilation, which by increasing the number of open capillaries could mask some permeability reducing effects measured by this CFC method. Prostacyclin, at doses up to 20 ng kg−1 min−1, just slightly reduced vascular tone indicating that these doses are indeed low for the cat. This also indicates that the reduction in CFC must be as a result of decreased capillary permeability as the number of open capillaries must be roughly unchanged. Prostacyclin in this model is far superior to terbutaline and theophyllamine in reducing capillary permeability and especially when considering the differences in their vasodilator effects. All these drugs are known to act by increasing intracellular cAMP which relaxes endothelial cells, decreasing capillary permeability. Prostacyclin is also thought to reduce permeability through an influence on leukocytes and platelets which could explain its more powerful permeability effect. This study indicates that low dose prostacyclin may be useful in pathophysiological states with increased capillary permeability. The effects of prostacyclin are under further evaluation in this intensive care unit.
Read full abstract